Cargando…

Lessons Learned from Post–COVID-19 Vaccination PET/CT Studies

Vaccination against coronavirus 2019 (COVID-19) has created new challenges. Lymphadenopathy with increased uptake in patients undergoing PET/CT may mislead to unnecessary further evaluation. We have analyzed routinely performed PET/CT studies after Pfizer-BioNTech vaccination to familiarize ourselve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Orevi, Marina, Chicheportiche, Alexandre, Ben Haim, Simona
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Society of Nuclear Medicine 2022
Materias:	Clinical Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978202/ https://www.ncbi.nlm.nih.gov/pubmed/34301777 http://dx.doi.org/10.2967/jnumed.121.262348

Ejemplares similares

Comparison of NEMA characterizations for Discovery MI and Discovery MI-DR TOF PET/CT systems at different sites and with other commercial PET/CT systems
por: Chicheportiche, Alexandre, et al.
Publicado: (2020)

[(18)F]-FDHT PET/CT as a tool for imaging androgen receptor expression in high-grade glioma
por: Orevi, Marina, et al.
Publicado: (2021)

False Positive Findings of [(18)F]PSMA-1007 PET/CT in Patients After Radical Prostatectomy with Undetectable Serum PSA Levels
por: Orevi, Marina, et al.
Publicado: (2022)

Can a penalized-likelihood estimation algorithm be used to reduce the injected dose or the acquisition time in (68)Ga-DOTATATE PET/CT studies?
por: Chicheportiche, Alexandre, et al.
Publicado: (2021)

COVID-19 vaccine as a cause for unilateral lymphadenopathy detected by 18F-FDG PET/CT in a patient affected by melanoma
por: Avner, Mordechai, et al.
Publicado: (2021)

Temporary Reactive Response of Axillary Lymph Nodes to COVID-19 Vaccination on (18)F-rhPSMA-7.3 PET/CT in Patients with Prostate Cancer
por: Notohamiprodjo, Susan, et al.
Publicado: (2022)

Coordination and optimization of FDG PET/CT and COVID-19 vaccination; Lessons learned in the early stages of mass vaccination
por: McIntosh, Lacey J., et al.
Publicado: (2021)

(18) F-FDG PET/CT Imaging of Boari Flap Mimicking Urothelial Cancer Recurrence
por: Fishberg, Sharon E., et al.
Publicado: (2022)

Incidental Findings Suggestive of COVID-19 Pneumonia in Oncologic Patients Undergoing (18)F-FDG PET/CT Studies: Association Between Metabolic and Structural Lung Changes
por: Wakfie-Corieh, Cristina Gamila, et al.
Publicado: (2022)

Superior Tumor Detection for (68)Ga-FAPI-46 Versus (18)F-FDG PET/CT and Conventional CT in Patients with Cholangiocarcinoma
por: Pabst, Kim M., et al.
Publicado: (2023)

Dosimetry after peptide receptor radionuclide therapy: impact of reduced number of post-treatment studies on absorbed dose calculation and on patient management
por: Chicheportiche, Alexandre, et al.
Publicado: (2020)

Feasibility of Acquisitions Using Total-Body PET/CT with an Ultra-Low (18)F-FDG Activity
por: Hu, Yan, et al.
Publicado: (2022)

Staging Prostate Cancer with (68)Ga-PSMA-11 PET/CT in the Elderly: Is Preimaging Biopsy Imperative?
por: Kesler, Mikhail, et al.
Publicado: (2023)

Operational challenges and mitigation measures during the COVID-19 pandemic–Lessons from DELIVER
por: Bhatt, Ankeet S., et al.
Publicado: (2023)

Blind spots at oncological CT: lessons learned from PET/CT
por: Sosna, Jacob, et al.
Publicado: (2012)

Impact of (68)Ga-FAPI PET/CT on Staging and Oncologic Management in a Cohort of 226 Patients with Various Cancers
por: Koerber, Stefan A., et al.
Publicado: (2023)

Towards accurate (177)Lu SPECT activity quantification and standardization using lesion-to-background voxel ratio
por: Raskin, Stanislav, et al.
Publicado: (2023)

Simple model for estimation of absorbed dose by organs and tumors after PRRT from a single SPECT/CT study
por: Chicheportiche, Alexandre, et al.
Publicado: (2021)

(18)F-FLT PET/CT as a Prognostic Imaging Biomarker of Disease-Specific Survival in Patients with Primary Soft-Tissue Sarcoma
por: Crompton, Joseph G., et al.
Publicado: (2022)

Prostate-Specific Membrane Antigen Expression on PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer: A Retrospective Observational Study
por: Calderoni, Letizia, et al.
Publicado: (2023)

Prognostic Value of Postinduction Chemotherapy Volumetric PET/CT Parameters for Stage IIIA or IIIB Non–Small Cell Lung Cancer Patients Receiving Definitive Chemoradiotherapy
por: Guberina, Maja, et al.
Publicado: (2021)

Perception, Prevalence, and Prediction of Severe Infection and Post-acute Sequelae of COVID-19
por: Knight, Dacre R.T., et al.
Publicado: (2022)

Novel Framework for Treatment Response Evaluation Using PSMA PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer (RECIP 1.0): An International Multicenter Study
por: Gafita, Andrei, et al.
Publicado: (2022)

Brain tumor patients and COVID-19 vaccines: results of an international survey
por: Voisin, Mathew R, et al.
Publicado: (2022)

A multicenter study of ocular inflammation after COVID-19 vaccination
por: Yasaka, Yuta, et al.
Publicado: (2022)

Phase I Study of [(68)Ga]Ga-Anti-CD206-sdAb for PET/CT Assessment of Protumorigenic Macrophage Presence in Solid Tumors (MMR Phase I)
por: Gondry, Odrade, et al.
Publicado: (2023)

A VISION Substudy of Reader Agreement on (68)Ga-PSMA-11 PET/CT Scan Interpretation to Determine Patient Eligibility for (177)Lu-PSMA-617 Radioligand Therapy
por: Kuo, Phillip H., et al.
Publicado: (2023)

(68)Ga-Labeled Fibroblast Activation Protein Inhibitor PET/CT for the Early and Late Prediction of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer Patients: A Prospective Study
por: Chen, Ling, et al.
Publicado: (2023)

Imaging of COVID-19 Vaccination at FDG PET/CT
por: Eifer, Michal, et al.
Publicado: (2021)

Lessons learned from chest CT in COVID-19
por: Soyer, P.
Publicado: (2020)

(18)F-fluorodeoxyglucose PET/CT findings in a systemic inflammatory response syndrome after COVID-19 vaccine
por: Steinberg, Julie, et al.
Publicado: (2021)

Future psychiatric services in Italy: lesson from the COVID-19 pandemic
por: Pelizza, Lorenzo, et al.
Publicado: (2020)

Phase III Study of (18)F-PSMA-1007 Versus (18)F-Fluorocholine PET/CT for Localization of Prostate Cancer Biochemical Recurrence: A Prospective, Randomized, Crossover Multicenter Study
por: Olivier, Pierre, et al.
Publicado: (2023)

Diagnostic Performance and Clinical Impact of (68)Ga-PSMA-11 PET/CT Imaging in Early Relapsed Prostate Cancer After Radical Therapy: A Prospective Multicenter Study (IAEA-PSMA Study)
por: Cerci, Juliano J., et al.
Publicado: (2022)

The COVID-19 pandemic: impact on NHS England PET-CT services and lessons learnt
por: Wong, Wai Lup, et al.
Publicado: (2020)

The Role of (11)C-Choline-PET/CT-Guided Secondary Lymphadenectomy in Patients with PSA Failure after Radical Prostatectomy: Lessons Learned from Eight Cases
por: Martini, Thomas, et al.
Publicado: (2012)

CT Quantification and Machine-learning Models for Assessment of Disease Severity and Prognosis of COVID-19 Patients
por: Cai, Wenli, et al.
Publicado: (2020)

CT-Guided Liver Biopsy: Evaluation of Spectral Data From Dual-Layer Detector CT for Improved Lesion Detection
por: Sauter, Andreas P., et al.
Publicado: (2023)

PET-Based Staging Is Cost-Effective in Early-Stage Follicular Lymphoma
por: Lo, Andrea C., et al.
Publicado: (2022)

Combination of coronary CT angiography, FFR(CT), and risk factors in the prediction of major adverse cardiovascular events in patients suspected CAD
por: Wada, Shinichi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_69pnqi2uhip9vc0j2gvkfa584p